ArticleEvidence-based complementary and alternative medicine : eCAM2018
Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials.Nutrients · 2024Pooled it
- Unveiling the Antidiabetic Potential ofMetabolites · 2026Article
- Antiobesity, antidiabetic, and antioxidant activities of selectedTurkish journal of medical sciences · 2026Article
- Review
- The Box-Behnken Design for Optimizing HPLC Separation and Validation of Astilbin inScientifica · 2024Article
- A comprehensiveFrontiers in pharmacology · 2024Review
- Antioxidant and In Vivo Hypoglycemic Activities of Ethanol Extract from the Leaves ofFoods (Basel, Switzerland) · 2023Article
- Review
- Eco-Friendly Solution Based onInternational journal of molecular sciences · 2022Article
- Influence of different pretreatments and drying methods on the chemical compositions and bioactivities of Smilacis Glabrae Rhizoma.Chinese medicine · 2022Article
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4Frontiers in pharmacology · 2022Article
- Uses, abundance perception, and potential geographical distribution of Smilax aristolochiifolia Mill (SMILACACEAE) on the Totonacapan Region of Puebla, Mexico.Journal of ethnobiology and ethnomedicine · 2021Article
- Glycoside Hydrolases and Non-Enzymatic Glycation Inhibitory Potential ofAntioxidants (Basel, Switzerland) · 2021Article
- Effect-Directed Profiling of 17 Different Fortified Plant Extracts by High-Performance Thin-Layer Chromatography Combined with Six Planar Assays and High-Resolution Mass Spectrometry.Molecules (Basel, Switzerland) · 2021Article
- A Review on Antidiabetic Activity ofEvidence-based complementary and alternative medicine : eCAM · 2021Review
- Molecules Isolated from Mexican Hypoglycemic Plants: A Review.Molecules (Basel, Switzerland) · 2020Review
- Use of Chlorogenic Acid against Diabetes Mellitus and Its Complications.Journal of immunology research · 2020Review
- Glucose-6-Phosphatase and α-Glucosidase Inhibitors fromRevista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2020Article
- GC-MS Analysis and Inhibitory Evaluation ofEvidence-based complementary and alternative medicine : eCAM · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regulating activities of
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.